Aleksey M. Kazakov

Aleksey M. Kazakov

Auto-generated profile, based on publicly available information

Aleksey M. Kazakov

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2020 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
KLK. K. Laktionov
K. K. Laktionov
AKA. M. Kazakov
A. M. Kazakov
ERE. V. Reutova
E. V. Reutova
MAM. S. Ardzinba
M. S. Ardzinba
AAA. L. Arzumanian
A. L. Arzumanian
The standard approach for stage IB and IIIIIA non-small cell lung cancer (NSCLC), associated with the high risk of relapse, after total lung resection is adjuvant chemotherapy, nowadays. The 5-year survival benefit for this approach is about 5%, and the risk of relapse reduces from 11 to 15%, depending on the stage. However, the relapse rate within 5 years after surgery and adjuvant chemotherapy in stage IBIIIA NSCLC is up to 70%. This fact requires the search for new solutions. The efficacy and safety profile of targeted drugs in metastatic NSCLC show the possibility to use them as adjuvant therapy in the early stages of the disease. This approach was actively studied in patients with mutations in the EGFR gene, and the most promising were the results of the ADAURA trial, which had been studied the use of Osimertinib, a third-generation EGFR tyrosine kinase inhibitor, as adjuvant therapy. The use of adjuvant targeted therapy in ALK-positive patients is currently less studied and its efficacy will be determined as the results of the ALINA and ALCHEMIST trials are obtained.

19 April 2019 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
DRD. L. Rotin
D. L. Rotin
KTK. S. Titov
K. S. Titov
AKA. M. Kazakov
A. M. Kazakov
The concept of vasculogenic mimicry (VM) was introduced to describe the unique ability of highly aggressive tumor cells to form capillary-like structures and matrix-rich patterned network in three-dimensional culture that mimic embryonic vasculogenic network. VM has been reported in several aggressive tumors including ovaries, breast, liver, lung cancer, sarcoma, glioblastoma. It is worth to note, that VM in melanocyte-originated tumors is the most studied. Although much attention has been focused on factors that stimulate or suppress vascular channel formation by tumor cells, the molecular mechanisms underlying this phenomenon remain enigmatic. This review will focus on molecular determinants and key signaling pathways involved in tumor VM. The exploration of drugs targeted at molecular signaling pathways in VM is a field of challenges and hopes. The research on VM will increase our knowledge of the molecular events causing aggressive tumor cells to gain plasticity resulting in their ability to mimic vasculature. To date, little functional data exist that show how tumor cell-lined channels contribute to the overall survival of the tumor. However, even among researches who have questioned the concept of VM as a crucial circulatory system, there is generally a consensus that the prognostic significance of PAS-positive patterns is valid.

30 March 2019 in Practical oncology
Verified
Journal Article
Open access
KTK.S. Titov
K.S. Titov
MBM.A. Baryshnikova
M.A. Baryshnikova
AKA.M. Kazakov
A.M. Kazakov
DKDmitry Khochenkov
Dmitry Khochenkov
ELE.P. Larionova
E.P. Larionova
DRD.A. Ryabchikov
D.A. Ryabchikov

1 January 2020 in Онкогинекология
Verified
Journal Article
Closed access
DRDenis A. Ryabchikov
Denis A. Ryabchikov
SCS.V. Chulkova
S.V. Chulkova
OTOrifjon A. Talipov
Orifjon A. Talipov
IVIgor K. Vorotnikov
Igor K. Vorotnikov
AKAleksey M. Kazakov
Aleksey M. Kazakov
FBFarangiz K. Berdova
Farangiz K. Berdova
Материалы и методы. В исследование включены 70 больных с верифицированным диагнозом рак молочной железы в возрасте от 30 до 72 лет. Преобладали больные со II (51,4%) и III (31,4%) стадиями. Метастазы в лимфатических лимфоузлах наблюдались в 60% случаев. Инвазивный протоковый рак выявлен в 72,8% случаев, инвазивный дольковый рак - в 12,8% случаев, у 14,4% пациентов диагностированы другие формы рака. У большинства больных (74,2%) рак молочной железы (РМЖ) был умеренной дифференцировки, в 21,4% случаев отмечена низкая дифференцировка, и только 4,4% пациентов имели высокодифференцированную опухоль. Люминальный подтип А установлен у 27,1% больных; люминальный подтип В Her2-негативный - у 18,5% больных; в 32,8% случаях - люминальный подтип В Her2-позитивный, трижды негативный - в 14,2% и нелюминальный Her2(+) позитивный подтип - в 7,1% случаев. Методом метил-специфичной полимеразной цепной реакции (МС-ПЦР) изучен профиль метилирования генов микроРНК (miR-107, -124a-1/2/3, -125b-1, -127, -130b, -137, -203a, -375) в парных образцах опухолевой и гистологически неизмененной ткани молочных желез. Полученные результаты обработаны стандартными пакетами STATISTICA, v. 10 и IBM SPSS Statistics, v. 21. Результаты. В ходе работы установлено, что при люминальном A подтипе РМЖ частота метилирования miR-124a-1 и miR-125b-1 в опухолевой ткани увеличена в 2,3 (84,2% (n = 16) против 36,8% (n = 7), р = 0,0069) и в 8 раз (42,1% (n = 8) против 15,8% (n = 1), p = 0,0189), соответственно, по сравнению с неизмененной тканью молочной железы. При Her2-негативном и при Her2-позитивном люминальном В подтипе показаны достоверные различия в частоте метилирования генов микроРНК miR-124a-1, miR-375 в опухоли и гистологически неизмененной ткани. Частота метилирования этих микроРНК при Her2-позитивном подтипе составила 69,5% (16/23) против 17,3% (4/23), (р = 0,0008) и 43,4% (10/23) против 13% (3/23), (р = 0,0472), соответственно. Для Her2-негативного рака эти значения были следующими: 84,6% (11/13) против 38,4% (5/13), (p = 0,04) и 69,2% (9/13) против 23% (3/13), (p = 0,04), соответственно. Установлена высокая частота метилирования miR-124a-3 и miR-125b-1 при Her2-позитивном B подтипе РМЖ. При трижды негативном подтипе метилирование miR-125b-1 в опухолевой ткани наблюдалось в большинстве образцов (70% (n = 7), р = 0,0075) и отсутствовало в гистологически неизмененной ткани. Заключение. Все исследуемые микроРНК демонстрировали повышенные уровни метилирования CpG-островков промоторных областей, что свидетельствует об их потенциальной диагностической значимости. Частота метилирования miR-375 достоверно повышена в опухоли при трижды негативном подтипе в сравнении с люминальным B Her2-негативным подтипом РМЖ. Для Her2-позитивного люминального В подтипа отмечен высокий процент метилирования 6 микроРНК (miR-124a-1, miR-375, miR-124a-3 и miR-125b-1, miR-127,...

25 November 2018 in Russian Journal of Biotherapy
Verified
Journal Article
Open access
PDF file
KTK. S. Titov
K. S. Titov
DRD. L. Rotin
D. L. Rotin
AKA. M. Kazakov
A. M. Kazakov
OMO. U. Micheeva
O. U. Micheeva
ITI. M. Telezhnikova
I. M. Telezhnikova
DRD. A. Ryabchikov
D. A. Ryabchikov
Objective.Determine the frequency of occurrence of tyrosine kinase expression of the mutated ALK and TAG-72 gene among patients with primary melanoma of the skin, to identify their association with a number of histological parameters, and to assess the diagnostic value of the determination of ALK and TAG-72.Materials and methods.Paraffin blocks with surgical material from 40 patients with primary skin melanoma. For routine histological examination, the material was fixed with 10 % neutral formalin for 24 h, poured into paraffin, sections were prepared with a thickness of 4–5 μm, stained with hematoxylin and eosin. IHC study with monoclonal antibodies D57.3 to ALK was performed on an immunostender – Ventana, with antibodies B72.3 to TAG-72 – on Thermo Fischer. As a detection system used: Envision – for TAG-72 and Ventana – for ALK.Results.ALK mutation was detected in 7 (12 %), TAG-72 – 4 (10 %) cases. Evaluation of the correlation force between the presence of ALK and TAG-72 showed a direct average coupling strength (correlation coefficient was 0.31). A direct correlation of the mean force between the presence of TAG-72 oncoprotein, ALK mutation and ulceration in the patient was found – the correlation coefficient was 0.53 and 0.68, respectively. There was a statistically significant association between the presence of ALK and lymphoid infiltration, which in most cases (57 %) was pronounced (p 0.05).Conclusion.Comparing the positive sign of the expression of ALK – 17.5 % and TAG-72 – 10 %, and the positive of their simultaneous detection – 7.5 %, it can be concluded that further studies to determine their diagnostic value are promising. The presence of severe lymphoid infiltration in ALK-positive patients claims a diagnostic value in primary skin melanoma.

30 September 2023 in Practical oncology
Verified
Journal Article
Closed access
АKА.м. Kazakov
А.м. Kazakov
КLК.к. Laktionov
К.к. Laktionov
КSК.а. Sarantseva
К.а. Sarantseva
МGМ.G. Gordiev
М.G. Gordiev